Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension.
• Writing research protocols and reports, manuscripts, and patents • Managing various scientific projects • Conducting independent research that includes planning and execution of studies,…